We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIO Open to User Fees to Improve Patient Medication Information
BIO Open to User Fees to Improve Patient Medication Information
October 1, 2010
At an FDA public meeting held Sept. 27 to gather information on better ways to present information to patients about prescription medications, the Biotechnology Industry Organization (BIO) said it “is open to discussions” on industry user fees to fund FDA approval of standardized sponsor-created documents.